Cleared Traditional

2P-QDA FOOT PRESSURE SYSTEMS REAL TIME (K882139) - FDA 510(k) Clearance

Class I Physical Medicine device.

K882139 · Human Performance Technologies, Inc. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1988
Decision
30d
Days
Class 1
Risk

K882139 is an FDA 510(k) clearance for the 2P-QDA FOOT PRESSURE SYSTEMS REAL TIME. Classified as System, Pressure Measurement, Intermittent (product code JFC), Class I - General Controls.

Submitted by Human Performance Technologies, Inc. (East Setauket, US). The FDA issued a Cleared decision on June 22, 1988 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.1600 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Human Performance Technologies, Inc. devices

Submission Details

510(k) Number K882139 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1988
Decision Date June 22, 1988
Days to Decision 30 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 115d · This submission: 30d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JFC System, Pressure Measurement, Intermittent
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 890.1600
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.